Comments to FDA: International Drug Scheduling and Dextromethorphan

Share page:
Docket Number:
FDA-2008-N-0448

Comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of ten drug substances.

Related Posts

CHPA Statement on Valisure Citizen Petition